The large size of this cohort, prolonged follow-up (median of 5.0 years), high rates of microbiological diagnosis and frequent CD4 count and viral load measurements allowed us to calculate with greater precision than existing studies how long-term TB incidence rates vary according to duration of ART and degree of CD4 cell count recovery. The gene discussed is CD4; the disease is tuberculosis.